Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small...
Leadership
Daniel W. Paterson
President, CEO & Director
Daniel Calkins
Chief Financial Officer
Michael Glen Kauffman M.D., Ph.D.
President of Development & Director
Robert A. Weinberg Ph.D.Founder
Co-Founder & Chair of Scientific Advisory Board
Michelle Detwiler M.D., Ph.D.Founder
Co-Founder
Lori Horvat
Executive Vice President of Portfolio Strategy & Operations
Jonathan Pachter Ph.D.
Chief Scientific Officer
Julissa Viana
Vice President of Corporate Communications & Investor Relations
